Will the medical insurance price of Ceritinib be reduced in 2023?

Ceritinib/Ceritinib (Ceritinib) is a targeted therapy used to treat certain types of non-small cell lung cancer (NSCLC). It belongs to the tyrosine kinase inhibitor category and is mainly used to treat patients with ALK (tyrosine kinase) fusion-positive NSCLC.

Ceritinib/Ceritinib has been launched in China and has been included in medical insurance. Patients can purchase it domestically, but the price is high. Please consult your local pharmacy for details. Foreign original drugs are divided into original drugs and generic drugs. Foreign original drugs are mainly Swiss Novartis original drugs. Specification150mg*150The price is about13,500 yuan. Generic drugs mainly include Bangladeshi version, with specifications of 150mg*30 and the price is around 1,300 yuan. The ingredients of original drugs and generic drugs are basically the same.

ALKfusion-positive NSCLC is a specific subtype of lung cancer. The ALK gene and other gene fusions exist in its cancer cells, resulting in ALK kinase being abnormally active and promoting the growth and spread of cancer cells. Ceritinib/Ceritinib works against this abnormal ALK fusion protein. By inhibiting its activity, it blocks the proliferation and spread of cancer cells, thereby inhibiting the development of tumors.

Ceritinib/Ceritinib is an oral medication that is usually taken with a meal. During the period of use, patients need to strictly follow the doctor's medication instructions, take the medication on time, and undergo regular physical examinations and necessary laboratory tests to ensure the safety and effectiveness of the treatment.

Althoughceritinib/ceritinib is effective against many ALK fusion-positiveNSCLCIt is an effective treatment option for patients, but it may also cause some adverse effects. Common adverse reactions include nausea, vomiting, diarrhea, fatigue, etc., while serious adverse reactions may include lung problems, cardiac arrhythmia, etc. Therefore, while using ceritinib/ceritinib, patients need to pay close attention to their physical condition and report any new symptoms or discomfort to their doctor at any time.